Frontiers in Radiopharmaceutical Therapy

Cambridge Healthtech Institute's 2nd annual Frontiers in Radiopharmaceutical Therapy conference spotlights the latest advances and clinical breakthroughs in radiolabelled therapies, with a special emphasis on emerging isotopes, dosimetry, combination treatments and next-generation platforms that are reshaping patient outcomes. Attendees can expect to explore new data from early preclinical and clinical trials, lessons learned in adaptive dosing and sequencing, innovative strategies and theranostic approaches targeting a spectrum of solid tumors. The conference will also highlight the regulatory perspectives and patient stratification tactics that are driving the field forward.

For more details on the conference, please contact:

Mimi Langley

Executive Director, Conferences

Cambridge Healthtech Institute

Email: mlangley@healthtech.com

For sponsorship information, please contact:

Companies A-K

Jason Gerardi

Sr. Manager, Business Development

Cambridge Healthtech Institute

Phone: 781-972-5452

Email: jgerardi@healthtech.com

Companies L-Z

Ashley Parsons

Manager, Business Development

Cambridge Healthtech Institute

Phone: 781-972-1340

Email: ashleyparsons@healthtech.com

2026 PROGRAMS

View By:

• Display of Biologics
• Engineering Antibodies
• Machine Learning for Protein Engineering

• Antibodies for Cancer Therapy
• Emerging Targets for Oncology & Beyond
• Driving Clinical Success in Antibody-Drug Conjugates

• TS: Intro to Multispecific Antibodies
• Advancing Multispecific Antibodies
• Engineering Bispecific and Multispecific Antibodies

• Emerging T Cell Engagers
• Advances in Immunotherapy
• Next-Generation Immunotherapies

• Difficult-to-Express Proteins
• Optimizing Protein Expression
• Maximizing Protein Production Workflows

• ML and Digital Integration in Biotherapeutic Analytics
• Biophysical Methods
• Characterization for Novel Biotherapeutics

• TS: Intro to Immunogenicity
• Predicting Immunogenicity with AI/ML Tools
• TS: Bioassay Development and Analysis

• Biologics for Autoimmune Diseases
• Frontiers in Radiopharmaceutical Therapy
• Emerging Peptide Therapeutics

• ML and Digital Integration in Biotherapeutic Analytics
• Predicting Immunogenicity with AI/ML Tools
• Machine Learning for Protein Engineering